Targeting refractory prostate cancer: a novel radiopharmaceutical hits the bull’s-eye
Researchers from Osaka University and Dusseldorf University have found a new theranostic compound that effectively shrinks prostate tumor in mice. Theranostics ...
存在位置
Research Info
/
2022
